EECP

About EECP

Enhanced External Counterpulsation (EECP®) is non-surgical, requires no medication and is a safe outpatient treatment option for people suffering from a diseased or weakened heart that includes angina pectoris (chest pain) and/or heart failure. Vasomedical, Inc. owns the registered trademark for EECP. At Global Cardio Care Centers, EECP is prescribed by a cardiologist for people with end-stage cardiovascular disease and also prior to heart-bypass surgery or angioplasty with stents.

Our physicians see positive improvement as a result of EECP treatment for people suffering from stroke, diabetes, coronary artery disease, high blood pressure, angina/chest pain, heart failure, heart attack, and diseases like obesity, kidney failure, eye disease, and more.

How EECP Works

You lie on a comfortable EECP bed. You are hooked to a heart monitor.

Three large blood-pressure-like cuffs wrap around the calves, thighs and lower buttocks.

When the heart is at rest, the cuffs squeeze the calves, thighs and buttocks in rapid sequence. Blood moves from lower legs back to the heart and through the entire body feeding heart tissue with oxygenated blood. When the heart pumps, the cuffs deflate rapidly and do not interfere with the body’s natural function. EECP treatment is like a second heart pumping while yours is at rest, like passive cardiovascular exercise.

During EECP:

Sheer force of reversed (from legs to heart), oxygenated blood flow increases.
Important hormones, gases and cells are secreted within the entire arterial system.
Nitric oxide is a molecule that contributes to dilation (widening) of the artery wall to increase blood flow throughout the body and all organs.
Vascular endothelial growth factor (VEGF) is a hormone that has been shown to stimulate growth of new collaterals and improved arterial function. VEGF is critical to the process of angiogenesis during EECP when new pathways form and naturally bypass blockages.
Progenitor cells and hematopoietic cells are dislodged from arterial walls and enter circulation. The new stem cells replace old cells and repair damaged tissue while promoting regeneration of the arterial system and organs throughout the body.
Circulating stem cells restore, repair, recover and regenerate damaged tissue in the heart and all other organs.
Inflammation within the body decreases; inflammation is known to be the balance between health and disease.
Exercise promotes an increase in circulating stem cells.
EECP is considered to be passive exercise, and circulating stem cells increase during treatment.
Increasing circulating stem cells is a component of regenerative therapy.
Clinical benefits are long-term even after completion of 35 hours of EECP therapy.
At Global Cardio Care Centers, patients with degenerative diseases including diabetes, peripheral neuropathy, Parkinson’s disease, stroke, arterial disease, and myocardial infarction have been known to functionally improve after several courses of EECP therapy.
EECP is an alternate therapy for people who need heart-bypass surgery, angioplasty or stents. EECP stimulates new arterial (collaterals) growth wherever blockages occur within your body’s arteries.

The History of EECP

Early counterpulsation therapy was done with hydraulics at Harvard University.

Was invented at Harvard University in the late 1950s
Is safe, non-surgical and medication free
Was approved by the U.S. Food & Drug Administration (FDA):
1970s for heart attack and cardiogenic shock
1995 for angina pectoris at any stage
2002 for congestive heart failure
Was approved by the Centers for Medicare & Medicaid Services:
2000 for angina pectoris end stage only

EECP is a treatment for the following diseases or conditions:

Angina pectoris
Congestive heart failure
Hypertension
Stroke
Diabetes
Peripheral artery disease
Leg pain
Renal failure
Fatigue
Shortness of breath
Poor circulation
Sports enhancement
Erectile dysfunction
Quality of life
Exercise duration and increased stamina
EECP Proof Points

Clinical research has shown EECP promotes angiogenesis described as growth of new collaterals for blood to naturally flow around blocked arteries. In Jan. 2010, scientists published a study in the journal Frontiers in Bioscience explaining that EECP is a regenerative therapy and stimulates growth of stem cells.

Professionals in the field of EECP are discovering more about how EECP positively affects the body’s circulation, inflammation and cardiovascular health by repairing, restoring, rejuvenating and re-growing organs and tissue throughout the body.

Hundreds of clinical research studies prove that EECP positively influences cardiovascular health in a variety of ways.

EECP has been proven to:

Treat/improve ischemic (diseased) heart tissue
Improve the effects of angina pectoris (chest pain)
Positively improve congestive heart failure
Promote regeneration of organs
Stimulate angiogenesis (growth of new arteries)
Eliminate/reduce angina pectoris (chest pain)
Reduce/reverse arterial stiffness (blood pressure)
Improve neuro-hormones
Improve function of endothelial (arterial) system
Have long-term, sustained effects
EECP World-Wide

At Global Cardio Care Centers, people with a variety of diseases can be treated with EECP therapy. We focus on prevention of disease and education, not just end-stage of life cardiovascular treatment. That’s how we differentiate Global Cardio Care Centers’ services over other institutions.

EECP is growing in importance and is performed at more than 500 academic institutions and independent physician practices throughout the U.S. and 13 other countries:

The Cleveland Clinic
Beth Israel Medical Center
Columbia University
Harvard Medical Center
Johns Hopkins Medical Center
The Mayo Clinic
The Miami Heart Institute
Texas Heart Institute
University of California,
Los Angeles
University of California, San Diego
University of California, San Francisco
Stony Brook University

Take the first step toward healthier longevity. If you, or someone you know, suffer from cardiovascular disease.